HP
Hybio Pharmaceutical
🇨🇳XSHE.300199ChinaHealthcare
CNÂ¥21.21CNYup +0.24 (+1.14%)ClosedEnd of day9:47 PM
PriceCNÂ¥21.21+0.24 (+1.14%)
Profile
- Healthcare
- Drug Manufacturers - Specialty & Generic
- China
Identity
- Exchange
- Shenzhen Stock Exchange . XSHE
- Type
- Stock
- ISIN
- CNE1000011T7
- CUSIP
- Not reported
Company
- Employees
- 1,035
- Headquarters
- Wuhan, China
- Website
- https://www.hybio.com.cn
Market
- Shares outstanding
- 883.2M
- Market cap
- CNÂ¥18.73B
Highlights
- Market cap
- CNÂ¥18.73B
- EPS LTM
- -CNÂ¥0.02calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- 0.55%calculatedCalculated by Finzer, not reported by the data provider.
Fundamentals (LTM)
- Revenue
- CNÂ¥883.92M+144.29%up year on year
- Net income
- -CNÂ¥17.83M+96.36%up year on year
- Gross margin
- 59.56%+60.25%up year on year
- Free cash flow
- CNÂ¥138.51M+1,874.99%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.